Cosmo Pharmaceuticals

Cosmo Pharmaceuticals

Pharmaceutical Manufacturing

Dublin, Ireland 17,809 followers

We develop innovative treatments that address significant unmet clinical needs

About us

Cosmo Pharmaceuticals improve people's lives by developing innovative treatments that address significant unmet clinical needs and improve clinical outcomes in the field of gastroenterology and endoscopy. Our clinical development pipeline specifically addresses innovative treatments for gastro-intestinal diseases and Colon Infections. Our effort is aimed to reduce the incidence of Colorectal Cancer (CRC) by increasing the detection rate of pre-cancerous lesions during colonoscopy. Along with our presence in drugs manufacturing, we have significant innovative research and operations supporting our growing portfolio of specialty products. Learn more at www.cosmopharma.com/.

Industry
Pharmaceutical Manufacturing
Company size
201-500 employees
Headquarters
Dublin, Ireland
Type
Public Company
Founded
1997
Specialties
drugs, medicines, specialty medicines, pain care, IBD, drugs manufacturing, Bowel Diseases, Colon Infections, Colorectal Cancer, gastro-intestinal diseases, endoscopy, AI, Artifical Intelligence, pharma, and colorectal

Locations

Employees at Cosmo Pharmaceuticals

Updates

Affiliated pages

Similar pages

Funding

Cosmo Pharmaceuticals 1 total round

Last Round

Post IPO debt

US$ 25.0M

See more info on crunchbase